Dual-Function Mammography, Prone Stereotactic Biopsy System Cleared by FDA

March 13, 2012 – Fischer Medical Technologies LLC (Fisher Medical), announces from the National Interdisciplinary Breast Center Conference that it has been named exclusive U.S. distributor of GIOTTO’s Full Field Digital Mammography (FFDM) systems.

After receiving 510(k) clearance by the FDA in November 2011 for the GIOTTO FFDM system, I.M.S. Srl (Internazionale Medico Scientifica) of Bologna Italy and Fischer Medical of Broomfield, Colo. signed a multiyear distribution agreement.  The newly-formed Fischer-GIOTTO division is headed by Bob Rusk, who formerly managed GIOTTO-USA.

The unique design of the GIOTTO system makes it possible to dedicate a single room for both upright mammography, as well as prone stereotactic biopsy.  The innovative tilting gantry ensures optimal positioning so that more breast tissue is included in the imaging field, increasing the ability to detect small cancers on the chest wall.  It also enables the mammogram procedure to be done “face to face;” a benefit to radiologists, technologists and patients alike.  The ring design of the GIOTTO system allows easy positioning of disabled wheelchair patients – the only known mammography system with this capability.

Morgan W. Nields, chairman and CEO of Fischer Medical said, “We are delighted with this agreement since the GIOTTO FFDM system has been installed in over 500 sites around the world and has demonstrated a proven track record of superb image quality and reliability.”

Vice President of International Sales at IMS in Bologna, Achille Alabanse said, “We have been gaining market share throughout the world and are very pleased to join forces with Fischer Medical. This agreement leverages Fischer’s deep knowledge and installed base of prone biopsy systems in the United States.”

For more information: www.giottousa.com


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
Subscribe Now